Literature DB >> 25826722

Prolonged proteasome inhibition cyclically upregulates Oct3/4 and Nanog gene expression, but reduces induced pluripotent stem cell colony formation.

Z Elizabeth Floyd, Elizabeth Z Floyd1, Jaroslaw Staszkiewicz, Rachel A Power, Gail Kilroy, Heather Kirk-Ballard, Christian W Barnes, Karen L Strickler, Jong S Rim, Lettie L Harkins, Ru Gao, Jeong Kim, Kenneth J Eilertsen.   

Abstract

There is ample evidence that the ubiquitin-proteasome system is an important regulator of transcription and its activity is necessary for maintaining pluripotency and promoting cellular reprogramming. Moreover, proteasome activity contributes to maintaining the open chromatin structure found in pluripotent stem cells, acting as a transcriptional inhibitor at specific gene loci generally associated with differentiation. The current study was designed to understand further the role of proteasome inhibition in reprogramming and its ability to modulate endogenous expression of pluripotency-related genes and induced pluripotent stem cells (iPSCs) colony formation. Herein, we demonstrate that acute combinatorial treatment with the proteasome inhibitors MG101 or MG132 and the histone deacetylase (HDAC) inhibitor valproic acid (VPA) increases gene expression of the pluripotency marker Oct3/4, and that MG101 alone is as effective as VPA in the induction of Oct3/4 mRNA expression in fibroblasts. Prolonged proteasome inhibition cyclically upregulates gene expression of Oct3/4 and Nanog, but reduces colony formation in the presence of the iPSC induction cocktail. In conclusion, our results demonstrate that the 26S proteasome is an essential modulator in the reprogramming process. Its inhibition enhances expression of pluripotency-related genes; however, efficient colony formation requires proteasome activity. Therefore, discovery of small molecules that increase proteasome activity might lead to more efficient cell reprogramming and generation of pluripotent cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25826722      PMCID: PMC4378358          DOI: 10.1089/cell.2014.0030

Source DB:  PubMed          Journal:  Cell Reprogram        ISSN: 2152-4971            Impact factor:   1.987


  53 in total

Review 1.  How the ubiquitin-proteasome system controls transcription.

Authors:  Masafumi Muratani; William P Tansey
Journal:  Nat Rev Mol Cell Biol       Date:  2003-03       Impact factor: 94.444

2.  Aberrant spindle assembly checkpoint in bovine somatic cell nuclear transfer oocytes.

Authors:  Tetsuya Tani; Yoko Kato; Yukio Tsunoda
Journal:  Front Biosci       Date:  2007-01-01

Review 3.  Concise review: role and function of the ubiquitin-proteasome system in mammalian stem and progenitor cells.

Authors:  Cord Naujokat; Tomo Sarić
Journal:  Stem Cells       Date:  2007-07-19       Impact factor: 6.277

4.  Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells.

Authors:  H Niwa; J Miyazaki; A G Smith
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

5.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.

Authors:  K L Rock; C Gramm; L Rothstein; K Clark; R Stein; L Dick; D Hwang; A L Goldberg
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

6.  Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1.

Authors:  Jinqiu Zhang; Wai-Leong Tam; Guo Qing Tong; Qiang Wu; Hsiao-Yun Chan; Boon-Seng Soh; Yuefei Lou; Jianchang Yang; Yupo Ma; Li Chai; Huck-Hui Ng; Thomas Lufkin; Paul Robson; Bing Lim
Journal:  Nat Cell Biol       Date:  2006-09-17       Impact factor: 28.824

7.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

8.  Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine.

Authors:  S Tsubuki; Y Saito; M Tomioka; H Ito; S Kawashima
Journal:  J Biochem       Date:  1996-03       Impact factor: 3.387

9.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

10.  The proteasome restricts permissive transcription at tissue-specific gene loci in embryonic stem cells.

Authors:  Henrietta Szutorisz; Andrew Georgiou; László Tora; Niall Dillon
Journal:  Cell       Date:  2006-12-29       Impact factor: 41.582

View more
  2 in total

1.  S100A16 up-regulates Oct4 and Nanog expression in cancer stem-like cells of Yumoto human cervical carcinoma cells.

Authors:  Nariaki Tomiyama; Ryuji Ikeda; Yukihiko Nishizawa; Shogo Masuda; Yusuke Tajitsu; Yasuo Takeda
Journal:  Oncol Lett       Date:  2018-04-25       Impact factor: 2.967

2.  Proteasomes in Protein Homeostasis of Pluripotent Stem Cells.

Authors:  A V Selenina; A S Tsimokha; A N Tomilin
Journal:  Acta Naturae       Date:  2017 Jul-Sep       Impact factor: 1.845

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.